Showing results (391-400 of 586) with videos related to
Sort By:
Pageof 59
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategiesRebecca L Elstrom, Peter Martin, Katya Ostrow, et al.Current Gerontology and Geriatrics Research|October 12, 2010
Understanding centenarians' psychosocial dynamics and their contributions to health and quality of lifeLeonard W Poon, Peter Martin, Alex Bishop, et al.Journal of Alzheimer'S Disease : JAD|June 10, 2019
Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian StudyJirayu Tanprasertsuk, Elizabeth J Johnson, Mary Ann Johnson, et al.European Urology Focus|July 30, 2017
[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First ExperienceGlenn Bauman, Peter Martin, Jonathan D Thiessen, et al.Gastroenterology Research and Practice|November 2, 2020
Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound HealingMarie Kjaer, Wayne Russell, Peter Schjerling, et al.Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.Nutrients|June 12, 2026
Correction: Dyńka et al. Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets. Nutrients 2025, 17, 965Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 6, 2012
Understanding dementia prevalence among centenariansLeonard W Poon, John L Woodard, L Stephen Miller, et al.Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.Pageof 59